Companies and institutions with biological laboratories understand the importance of complying with the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) biosafety guidelines and the Bloodborne Pathogens Standard. Yet remaining in compliance can be demanding as research and development efforts continue to expand into new areas. Conducting a laboratory review to ensure compliance with existing guidelines and standards is a valuable investment.
This white paper outlines the biosafety review process and tells you how to maximize the benefits of your biosafety review.
To download a copy of the white paper, register by clicking here.